scabies
Information
- Disease name
- scabies
- Disease ID
- DOID:8295
- Description
- "A mite infestation that is a contagious ectoparasite skin infection caused by human itch mite Sarcoptes scabiei type hominis, which burrows into the upper layer of the skin but never below the stratum corneum causing severe itching and a rash found on the hands, folds of the wrist, elbow or knee, penis, breast, and shoulder blades." [url:http\://www.dpd.cdc.gov/dpdx/HTML/Scabies.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00262418 | Completed | Phase 2 | Comparison of the Efficacy and Safety of Ivermectin to Permethrin | July 2004 | May 2005 |
| NCT00604084 | Completed | N/A | Veron Scabies Education and Eradication Program | May 2007 | May 2008 |
| NCT00884728 | Completed | Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory | September 2004 | August 2007 | |
| NCT02094716 | Completed | Phase 2 | A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies | April 2014 | December 2014 |
| NCT02254564 | Completed | PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei | October 2014 | October 31, 2017 | |
| NCT02407782 | Completed | Phase 3 | Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults | January 19, 2016 | January 18, 2022 |
| NCT02485704 | Completed | Phase 3 | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | May 10, 2017 | August 3, 2018 |
| NCT02485717 | Completed | Phase 3 | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | May 2, 2017 | June 25, 2018 |
| NCT02572986 | Completed | Phase 3 | A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies | September 2015 | August 2016 |
| NCT02775617 | Completed | Phase 4 | Azithromycin - Ivermectin Mass Drug Administration for Skin Disease | July 2016 | February 5, 2018 |
| NCT02978508 | Completed | Phase 3 | Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies. | November 2016 | May 2017 |
| NCT03177993 | Completed | N/A | Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji | July 13, 2017 | October 24, 2019 |
| NCT03178942 | Completed | Phase 3 | Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies | June 1, 2017 | November 11, 2017 |
| NCT03236168 | Completed | Phase 3 | Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands | August 1, 2017 | February 28, 2018 |
| NCT03676140 | Completed | Phase 3 | Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) | October 1, 2018 | January 1, 2019 |
| NCT03905265 | Completed | Phase 2 | Dose-finding Study of Moxidectin for Treatment of Scabies | January 13, 2020 | February 28, 2022 |
| NCT03973775 | Completed | Phase 3 | A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies | April 10, 2018 | December 6, 2018 |
| NCT04205669 | Completed | Phase 4 | Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon | October 4, 2018 | February 21, 2019 |
| NCT05025696 | Completed | N/A | Efficacy and Side Effects of Blacksoap® as Adjuvant Therapy of Scabies | September 18, 2018 | December 30, 2019 |
| NCT05117528 | Completed | Streptococcus Pyogenes Carriage Acquisition and Transmission Study | July 27, 2021 | September 30, 2022 | |
| NCT05198947 | Completed | N/A | Better Disease Control by Multidrug Regimen in Scabies | January 2017 | July 2018 |
| NCT05362513 | Completed | Phase 1 | Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies | June 1, 2021 | November 30, 2021 |
| NCT05819983 | Completed | Phase 4 | Ivermectin/ Permethrin for Scabies | January 25, 2023 | March 6, 2023 |
| NCT05862701 | Completed | Phase 1 | Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies | March 1, 2022 | September 30, 2022 |
| NCT06396507 | Completed | Phase 3 | Sulfur vs. Different Regimes of Permethrin for Scabies | March 15, 2022 | November 12, 2022 |
| NCT05500326 | Not yet recruiting | Phase 2 | Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) | June 2024 | June 2026 |
| NCT06380452 | Not yet recruiting | Phase 3 | Therapy for Scabies With Two Differently Concentrated Permethrin Creams | May 2024 | December 2028 |
| NCT06404333 | Not yet recruiting | Phase 2 | Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15) | October 1, 2024 | December 31, 2025 |
| NCT04332068 | Recruiting | Phase 2 | Ivermectin Safety in Small Children | November 18, 2023 | December 2024 |
| NCT05310734 | Recruiting | Phase 4 | PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies | March 4, 2022 | March 31, 2026 |
| NCT05875441 | Recruiting | Phase 2 | Efficacy and Safety Study of Moxidectin in Adults With Scabies | November 23, 2023 | December 30, 2024 |
| NCT04844905 | Unknown status | Phase 3 | Adjunctive Ivermectin Mass Drug Administration for Malaria Control | May 3, 2021 | August 2023 |
| NCT04814511 | Unknown status | Phase 3 | Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin) | June 11, 2021 | August 2023 |
| NCT05271968 | Unknown status | N/A | Place of Hygiene in Scabies's Treatment in Populations in Precarious Situations | April 2022 | June 2022 |
| NCT04931680 | Unknown status | Risk Factors for Treatment Failure of Scabies in Autochthonous Populations of French Guiana (GUYAGALE) | March 29, 2021 | August 25, 2021 |
- Disase is a (Disease Ontology)
- DOID:7894
- Cross Reference ID (Disease Ontology)
- ICD10CM:B86
- Cross Reference ID (Disease Ontology)
- ICD9CM:133.0
- Cross Reference ID (Disease Ontology)
- MESH:D012532
- Cross Reference ID (Disease Ontology)
- NCI:C34998
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266224002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0036262
- Exact Synonym (Disease Ontology)
- Infestation by Sarcoptes scabiei
- Exact Synonym (Disease Ontology)
- Infestation by Sarcoptes scabiei var hominis
- Exact Synonym (Disease Ontology)
- Sarcoptic itch
- ICD10 preferred id (Insert disease from ICD10)
- D0000868
- ICD10 class code (Insert disease from ICD10)
- B86
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012532